Literature DB >> 5441073

N-demethylation the antineoplastic agent4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide by rats and man.

J L Skibba, D D Beal, G Ramirez, G T Bryan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5441073

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  [Carcinogenic activity of 13 aryldialkyl triazenes in BD-rats (author's transl)].

Authors:  R Preussmann; S Ivankovic; C Landschütz; J Gimmy; E Flohr; U Griesbach
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

Review 2.  Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.

Authors:  G J Sewell
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

3.  Clinical pharmacokinetics of high-dose DTIC.

Authors:  J M Buesa; E Urréchaga
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 4.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.

Authors:  H Breithaupt; A Dammann; K Aigner
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

6.  Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.

Authors:  P J Frosch; B M Czarnetzki; E Macher; E Grundmann; I Gottschalk
Journal:  J Cancer Res Clin Oncol       Date:  1979       Impact factor: 4.553

7.  Mechanisms of hepatotoxicity caused by dacarbazine in rats.

Authors:  R Paschke; M Heine; S Braun; K H Usadel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

8.  The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.

Authors:  P G Larsson; F Haffner; G O Brłnstad; T Christoffersen
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

9.  Synthesis and Molecular-cellular Mechanistic Study of Pyridine Derivative of Dacarbazine.

Authors:  Marzieh Amirmostofian; Jalal Pourahmad Jaktaji; Zohreh Soleimani; Kimia Tabib; Farahnaz Tanbakosazan; Mirdavood Omrani; Farzad Kobarfard
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 10.  Temozolomide and Other Alkylating Agents in Glioblastoma Therapy.

Authors:  Hannah Strobel; Tim Baisch; Rahel Fitzel; Katharina Schilberg; Markus D Siegelin; Georg Karpel-Massler; Klaus-Michael Debatin; Mike-Andrew Westhoff
Journal:  Biomedicines       Date:  2019-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.